42 / 88
42
Scientific Programme /
Tuesday, 20 June 2017
WFSBP 2017
TUE
018
Exp-ECT: The impact of patients' expectation on
effectiveness and tolerability of electroconvulsive
therapy
David Zilles, Germany
M. Belz, M. Besse, L. Krech, I. Methfessel, D. Wedekind
019
Anxiety attacks with or without life threaten-
ing situations, major depressive disorder, and suicide
attempt: A nationwide community sample of Korean
adults
Hye-Won Kim, Republic of Korea
K.-W. Kim, K.-W. Choi, H.-J. Jeon
021
Prevalence and use of mental health services
among subjects with comorbid mood and anxiety
disorders among Brazilians
Sergio Blay, Brazil
G. Fillenbaum, M. Mello, M. Quintana, J. Mari, R. Bressan,
S. Andreoli
022
Cholecalciferol treatment reverses depression-like
behavior and corticosterone levels in female rats with
experimental model of menopause
Julia Fedotova, Russia
S. Pivina, A. Sushko
P-07
POSTER TOUR
13:00–14:30
Congress Hall A 1
Inflammation
Chair:
Michael Maes, Thailand
001
Dyslipidemia in adolescents with early onset
psychosis
Kirsten Wedervang-Resell, Norway
V. Lonning, R. Smelror, K. B. Holven, S. Ulven, I. Agartz,
A. M. Myhre
002
A randomized controlled trial of mindfulness-
based cognitive therapy for youth living with Inflamma-
tory Bowel Disease (IBD) and depression
Tatjana Ewais, Australia
J. Begun
003
Retinoic acid signaling in anti-inflammatory effects
of minocycline
Vera Clemens, Germany
F. Regen, I. Heuser, J. Hellmann-Regen
004
Immune system dysregulation in the pathogenesis
of first-onset postpartum psychosis: Clues from peri-
pheral markers
Gopinath Sathyanarayanan, India
H. Thippeswamy, R. Mani, M. M. Venkataswamy,
M. Kumar, M. Philip, P. S. Chandra
005
C-reactive protein and white blood cell levels in
schizophrenia, Bipolar Disorders (BP) and depression
and associations with mortality and psychiatric out-
comes: A Danish population-based study
Henriette Thisted Horsdal, Denmark
O. Köhler, M. Eriksen Benros, C. Gasse
006
C-reactive protein levels and associations with
treatment resistance in schizophrenia: A Danish popula-
tion-based study
Henriette Thisted Horsdal, Denmark
T. Wimberley, M. Eriksen Benros, C. Gasse
007
A case report of comorbid schizophrenia and
psoriasis that illustrates the potential relationship
between response to antipsychotics and inmunity
Guillermo Joaquín Hönig, Argentina
S. Wikinski
008
Serum inflammatory biomarkers are adjunct diag-
nostic tools for schizophrenia in clinical practice
Shohei Nishimon, Japan
T. Ohnuma, Y. Takebayashi, N. Katsuta, M. Takeda,
T. Nakamura, T. Sannohe, R. Higashiyama, A. Kimoto,
N. Shibata, H. Arai
011
Serum high-sensitivity C-reactive protein, risk of
cardiovascular disease, and disease stages in patients
with schizophrenia
Jeffrey Yao, USA
R. Reddy, J. Gurklis, A. Sonel, E. Sonel, B. Kisslinger,
R. Chengappa, M. Keshavan, G. Haas
012
Peripheral levels of a pro-inflammatory metabolite
in the arachidonic acid cascade differentiate pharma-
cotherapy resistant from pharmacotherapy responding
major depressive disorder patients
Fotini Boufidou, Greece
M. Zoga, P. Oulis, V. G. Masdrakis, P. Pliatsika, S. Foteli,
C. Nikolaou
P-08
POSTER TOUR
13:00–14:30
Congress Hall A 1
Neuroimaging
Chair:
Gitte Moos Knudsen, Denmark
001
Brain-behavior correlation in a high risk for psy-
chiatric disorders Brazilian cohort: A replication study
Andrea Jackowski, Brazil
A. Zugman, E. Trejos-Castillo, A. Mastergeorge
002
Correlation between hypothalamus and third
ventricle of patients with affective disorders
Marie Stroske, Germany
S. Schindler, M. Storch, S. Geyer, P. Schönknecht